Related Experiment Videos
Adult acute lymphocytic leukemia. Future research directions
1Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. hkantarj@mdanderson.org
Hematology/Oncology Clinics of North America
|March 20, 2001
Abstract:
This article reviews future research of potential benefit to adults with acute lymphocytic leukemia (ALL). This new research includes dose intensive anthracyclines, novel agents, STI571 for Philadelphia chromosome-positive ALL, and risk-oriented strategies.